Archive for January 2018

The German Homeopathic Pharmacopeia

By Eric Foxman, AAHP secretary February 1, 2018 A quick look at its history, purpose and contents, as well as the potential for adulteration and misbranding violations in the United States. History The German homeopathic community and industry has a rich tradition of written pharmaceutical compendiums going back to the readm more…

Read More

United States Food and Drug Administration – Good Guidance Practices

By Mark Land, AAHP president February 1, 2018 The Food and Drug Administration (FDA) amended its administrative regulations to codify its policies and procedures for the development, issuance, and use of guidance documents in September 2000.1 This action was necessary to comply with requirements of the Food and Drug Administration readm more…

Read More

Prominence in Advertising and Labeling

By Mark Land, AAHP president February 1, 2018 A search under the term “prominence” yields 43 citations within Title 21 of the U.S. Code of Federal Regulations.1 Prominence appears 11 times in the Federal Food, Drug, and Cosmetic Act.2 The Food and Drug Administration says lack of prominence may render readm more…

Read More

Testing the New AAHP Disclaimer for Effectiveness

By Jeremy Kees, PhD, Professor, Marketing & Business Law and Faculty Director, Villanova University February 1, 2018 The American Association of Homeopathic Pharmacists (AAHP) enlisted my assistance in 2017 to design and conduct consumer comprehension studies for a number of possible advertising and label disclaimers. AAHP was in the process readm more…

Read More